Other OTC - Delayed Quote USD

Xtacy Therapeutics Corp. (XTCYF)

0.0533 0.0000 (0.00%)
At close: May 2 at 3:40 PM EDT
Loading Chart for XTCYF
DELL
  • Previous Close 0.0533
  • Open 0.0533
  • Bid --
  • Ask --
  • Day's Range 0.0533 - 0.0533
  • 52 Week Range 0.0068 - 0.2100
  • Volume 650
  • Avg. Volume 17,143
  • Market Cap (intraday) 2.908M
  • Beta (5Y Monthly) -0.67
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0100
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Global Wellness Strategies Inc. formerly known as Redfund Capital Corp. is an incubator and accelerator firm specializing in incubation. The firm seeks to invest in the public and private sectors that focus on preventative health, wellness issues and related consumer products. The firm seeks to invest in Canada. The firm also provides debt financing facility. Global Wellness Strategies Inc. was incorporated in 1998 and is headquartered in Vancouver, Canada with an additional office in Vancouver, Canada.

globalwellnessstrategies.com

--

Full Time Employees

September 30

Fiscal Year Ends

Recent News: XTCYF

Performance Overview: XTCYF

Trailing total returns as of 5/15/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

XTCYF
32.80%
S&P/TSX Composite index
6.33%

1-Year Return

XTCYF
62.13%
S&P/TSX Composite index
9.13%

3-Year Return

XTCYF
79.38%
S&P/TSX Composite index
15.07%

5-Year Return

XTCYF
87.89%
S&P/TSX Composite index
36.85%

Compare To: XTCYF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: XTCYF

Valuation Measures

Annual
As of 5/15/2024
  • Market Cap

    1.80M

  • Enterprise Value

    1.82M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    158.15

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    113.69

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -135.34%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -633.18k

  • Diluted EPS (ttm)

    -0.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -82.32k

Research Analysis: XTCYF

Company Insights: XTCYF

Research Reports: XTCYF

People Also Watch